SABS
SAB Biotherapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.15
-0.44 ▼ -9.59%
🌙 3월 13일 7:34 PM ET (한국 3/14 08:34)
$4.23
+0.08 ▲ +1.93%
| Index | - | P/E | - | EPS (ttm) | -2.67 | Insider Own | 27.74% | Shs Outstand | 0.05B | Perf Week | 9.5% |
| Market Cap | 0.21B | Forward P/E | - | EPS next Y | 37.62% | Insider Trans | - | Shs Float | 0.04B | Perf Month | -0.72% |
| Enterprise Value | 0.12B | PEG | - | EPS next Q | -0.21 | Inst Own | 55.65% | Short Float | 4.38% | Perf Quarter | 11.86% |
| Income | -0.01B | P/S | - | EPS this Y | 8.12% | Inst Trans | 22.33% | Short Ratio | 3.49 | Perf Half Y | 95.75% |
| Sales | 0.00B | P/B | 1.3 | EPS next 5Y | 15.91% | ROA | -11.62% | Short Interest | 1.61M | Perf YTD | 10.96% |
| Book/sh | 3.18 | P/C | 2.19 | EPS past 3/5Y | 43.07% - | ROE | -14.45% | 52W High | -37.12% ($6.60) | Perf Year | 154.6% |
| Cash/sh | 1.9 | P/FCF | - | Sales past 3/5Y | - | ROIC | -8.19% | 52W Low | 315% ($1.00) | Perf 3Y | -26.82% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 67.23% | Gross Margin | - | Volatility(W/M) | 12.48% 8.42% | Perf 5Y | -95.8% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.36 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 9.46 | EPS Q/Q | 33.75% | Profit Margin | - | RSI (14) | 52.68 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.46 | Sales Q/Q | -100% | SMA20 | 4.86% ($3.96) | Beta | 0.55 | Target Price | $10 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 3000000 | SMA50 | 3.33% ($4.02) | Rel Volume | 1.25 | Prev Close | $4.59 |
| Employees | 86 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | -2.95% - | SMA200 | 39.75% ($2.97) | Avg Volume(3M) | 0.46M | Price | $4.15 |
| IPO | 2021/2/9 | Option/Short | Yes/Yes | Trades | 4189 | Volume | 577,643 | Change | -9.59% |
뉴스 로딩 중...